Luigi Mangione’s lawyers seek to delay his state and federal trials

Lawyers Seek Trial Delay in UnitedHealthcare CEO Murder Case

Luigi Mangione’s defense team petitioned a federal judge on Wednesday to postpone his trial in the killing of UnitedHealthcare CEO Brian Thompson until early 2027, citing concerns about overlapping court schedules that could violate his constitutional rights.

In a letter to U.S. District Judge Margaret Garnett, Mangione’s attorneys argued that the current timeline—with a state murder trial in June and federal proceedings in September—would force the defendant to “prepare for two complicated and serious trials at the same time.”

The lawyers requested that Garnett delay the federal trial until January 2027, allowing them to petition state trial judge Gregory Carro to reschedule that case from June 8 to September 8. Mangione has pleaded not guilty in both jurisdictions.

The dual trials represent an unusual legal challenge in one of the most high-profile corporate homicide cases in recent years. Mangione, 27, faces potential life imprisonment if convicted in either case, though Judge Garnett previously barred federal prosecutors from seeking the death penalty by dismissing a key murder charge she found legally flawed.

“Though fierce advocates for their clients, defense counsel cannot be in two places at once,” wrote Mangione’s legal team, consisting of Karen Friedman Agnifilo, Marc Agnifilo, and Jacob Kaplan. They argue that simultaneous trial preparation would infringe on Mangione’s right to participate in his own defense, particularly during the critical jury selection process.

Federal prosecutors oppose the request and plan to respond with their own filing, according to Mangione’s attorneys. Both the U.S. attorney’s office in Manhattan and the Manhattan district attorney’s office declined to comment when contacted.

The case stems from the December 4, 2024 shooting of Thompson, who was killed while walking to a midtown Manhattan hotel for UnitedHealth Group’s annual investor conference. Surveillance footage captured a masked gunman shooting Thompson from behind. In a detail that gained significant media attention, authorities reported that the words “delay,” “deny,” and “depose” were written on the ammunition—seemingly referencing a phrase describing how insurance companies allegedly avoid paying claims.

Mangione, a University of Pennsylvania graduate from a wealthy Maryland family, was apprehended five days after the shooting at a McDonald’s restaurant in Altoona, Pennsylvania, approximately 230 miles west of Manhattan.

His attorneys have previously criticized law enforcement for turning his arrest into what they described as a “Marvel movie” spectacle. They specifically objected to armed officers parading Mangione up a Manhattan pier after he was flown to New York and publicly discussing pursuit of the death penalty before formal indictment.

During a February court hearing, Mangione himself spoke out against facing dual trials, telling the judge: “It’s the same trial twice. One plus one is two. Double jeopardy by any commonsense definition.”

The defense team emphasized in their letter that without delaying the federal trial, “Mr. Mangione’s potential federal jurors will be constantly bombarded with news reports and social media posts relating to the allegations and evidence against Mr. Mangione as they fill out juror questionnaires and in the subsequent weeks before they are empaneled in the federal case.”

The murder of Thompson sent shockwaves through the healthcare industry, where he had been a prominent figure. As CEO of UnitedHealthcare, the insurance division of UnitedHealth Group, Thompson oversaw operations for one of America’s largest health insurers, covering approximately 50 million people nationwide.

The unusual nature of the case—particularly the messaging allegedly inscribed on the ammunition—has drawn attention to broader tensions between healthcare consumers and insurance providers. Industry analysts note that the phrase “delay, deny, defend” has become a rallying cry among healthcare reform advocates who criticize insurance practices.

Judge Garnett is expected to rule on the scheduling request in the coming weeks, a decision that will significantly impact how this complex case proceeds through two separate court systems.